CAS 227803-63-6

Aclerastide

CAS : 227803-63-6

Aclerastide, an angiotensin receptor agonist, decreases fibrosis in wounds; effect increases with use duration, blocked by AT antagonist.

Formule : C₄₂H₆₄N₁₂O₁₁

Couleur et forme : Solid

Masse moléculaire : 913.03

Ref: TM-T26554

Aclerastide

Produit contrôlé

CAS : 227803-63-6

Applications Aclerastide is a peptide analog of angiotensin II, and a potential treatment for diabetic foot ulcers.
References Nguyen, T. T., et al.: Eur. J. Pharmacol., 834, 77 (2018); Rodgers, K., et al.: Expert. Opin. on Investig. Drugs, 20, 1575 (2011)

Formule : C₄₂H₆₄N₁₂O₁₁

Couleur et forme : Neat

Masse moléculaire : 913.031

Ref: TR-A115630

Aclerastide

CAS : 227803-63-6

Aclerastide is a synthetic peptide, which is a bioengineered molecule designed to mimic certain biological functions. Synthesized through advanced peptide chemistry, this product interacts with cellular pathways to promote wound repair and tissue regeneration. Its mode of action involves the modulation of cellular processes at the injury site, essentially accelerating natural healing mechanisms. Aclerastide achieves this by influencing growth factor activity and enhancing fibroblast function, contributing to improved extracellular matrix production and cellular proliferation.

Formule : C₄₂H₆₄N₁₂O₁₁

Degré de pureté : Min. 95%

Masse moléculaire : 912.48175

Ref: 3D-XA178185